Photo of Tom Powles taken from bartscancer.london
May 24, 2024, 00:08
Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“The ESMO guidlines make a clear distinction between papillary and other ‘non-clear cell’ renal cancers. Mixing these together has hampered new treatments. Sarcomatoid needs upfront PD1 combos. Other subgroups (chromaphobe etc) need more data.”
Further information.
Source: Tom Powles/X
Aug 12, 2024, 04:06